Results 11 to 20 of about 15,220 (247)

Methyldopa and Hypertension [PDF]

BMJ, 1963
A. W. Stott, R. Robinson, S. R. F. Whittaker   +2 more
openaire   +4 more sources

Acute Colitis due to Methyldopa [PDF]

Canadian Journal of Gastroenterology, 1989
A case of acute colitis due to antihypertensive therapy with methyldopa is reported . The colonic biopsies showed heavy infiltrates of eosinophils with crypt abscesses, cryptitis and vascular cuffing.
Michael Troster, Stephen N. Sullivan
doaj   +2 more sources

Hypotensive Action of Methyldopa [PDF]

BMJ, 1963
H. Smirk
openaire   +4 more sources

Antihypertensive therapy for pregnancy hypertension and implications for fetal and neonatal heart rate monitoring: A systematic review of randomized trials and observational studies. [PDF]

Acta Obstet Gynecol Scand
Trials are mostly reassuring regarding antihypertensive effects on fetal (FHR) or neonatal heart rate (neoHR), but observational studies raise concerns about beta‐blockers, particularly the alpha/beta‐blocker labetalol. Clinicians should ascribe adverse fetal or neonatal heart rate effects to evolving underlying placental dysfunction or newborn illness,
Ganeshamoorthy A, Duke OF, Mistry HD, Bone JN, Vidler M, Abalos E, Badawy K, Khalil A, von Dadelszen P, Magee LA.   +9 more
europepmc   +2 more sources

Methyldopa in the Treatment of Hypertension [PDF]

BMJ, 1963
Jozef Victor Joossens, Marc Verstraete, Ph Lauwers   +2 more
openaire   +4 more sources

Letter: Meditation or methyldopa? [PDF]

BMJ, 1976
D H Dighton, P G Nixon
openaire   +5 more sources

Should the non‐canonical pathway of nitric oxide generation be targeted in hypertensive pregnancies?

British Journal of Pharmacology, EarlyView., 2023
Abstract Hypertension in pregnancy is prevalent, affecting around 10% of pregnancies worldwide, and significantly increases the risk of adverse outcomes for both mothers and their babies. Current treatment strategies for pregnant women with hypertension are limited, and new approaches for the management of hypertension in pregnancy are urgently needed.
Elizabeth C. Cottrell
wiley   +1 more source

A Case of Drug-Resistant Renovascular Hypertension due to Renal Artery Stenosis Successfully Treated by Nephrectomy of the Affected Kidney. [PDF]

IJU Case Rep
ABSTRACT Introduction Renal artery stenosis (RAS) reduces renal blood flow and activates the renin‐angiotensin‐aldosterone (RAA) system, resulting in renovascular hypertension (RVH). Case Presentation We report a case of a 49‐year‐old woman with RVH due to bilateral renal artery stenosis, predominantly on the right.
Shimoda M, Otake S, Imano M, Aoki T, Karibe J, Shibata Y, Inoue M, Nagatomo A, Yakeishi M, Kobayashi K.   +9 more
europepmc   +2 more sources

An efficient electrochemical sensor based on CeVO4-CuWO4 nanocomposite for methyldopa

Materials Research Express, 2021
A novel modified electrode based on cerium vanadate and copper tungstate (CeVO _4 -CuWO _4 ) nanocomposite was prepared as a sensitive sensor for the methyldopa. The prepared nanocomposite was characterized by x-ray diffraction (XRD), energy dispersive x-
Hadi Halakoei, Masoumeh Ghalkhani, Ali Sobhani-Nasab, Mehdi Rahimi-Nasrabadi   +3 more
doaj   +1 more source

Analysis of Methyldopa Therapy on sFlt-1 Antiangiogenic Levels in Patients with Severe Preeclampsia

Folia Medica Indonesiana, 2018
Methyldopa is the first-line drugs to treat hypertension in pregnancy. It can decrease blood pressure in preeclampsia by affecting a2-adrenoreceptors in central nervous system. However, it could also act by decreasing  production of sFlt-1 antiangiogenic
Teri Wina Herwati, Yulistiani Yulistiani, Eddy Zarkaty M   +2 more
doaj   +1 more source